Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2101829-58-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6456263-01 0.2 mL
Gata6 (Transcription Factor GATA-6, GATA-Binding Factor 6, Gata6) (Biotin)
Ask
View Details MBS6456263-02 5x 0.2 mL
Gata6 (Transcription Factor GATA-6, GATA-Binding Factor 6, Gata6) (Biotin)
Ask
View Details 